0.00Open139.48Pre Close0 Volume19 Open Interest5325.00Strike Price0.00Turnover69.39%IV-0.56%PremiumSep 11, 2024Expiry Date170.52Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeEuropeanOptions Type0.9515Delta0.0010Gamma32.50Leverage Ratio-19.7455Theta0.0384Rho30.92Eff Leverage0.1525Vega
S&P 500 Index Stock Discussion
initial reaction = false move
$S&P 500 Index (.SPX.US)$ $Bitcoin (BTC.CC)$
As of September 10, Pfizer's stock price has risen by about 7% since June 2024, which could be just the beginning of its growth momentum. The pharmaceutical giant's non-COVID product line has performed strongly, and Wall Street analysts are predicting that its earnings per share will bottom out in fiscal year 2024, indicating that Pfizer's recovery is just starting.
In the second quart...
Adobe, with its leading position in the content creation software domain, continues to maintain robust revenue growth and profitability. However, the market is always full of uncertainties, and Adobe's stock price is not immune to fluctuations. This article will delve into Adobe's fundamentals and assess whether it is a worthy target for investors.
First, let's examine Adobe's c...
Recently, NVIDIA's stock price has undergone an adjustment, sparking widespread discussion in the market.
First, we need to clarify that NVIDIA's performance has not suffered any substantial setbacks. So, what are the reasons behind the stock price volatility? Essentially, this is the result of market expectations self-adjusting. Although NVIDIA's performance remains impressive, earlier mark...
No comment yet